Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Yi‐Fang Ping"'
Autor:
Pei-Pei Zhang, Zhi-Cheng He, Xiao-Hong Yao, Rui Tang, Jie Ma, Tao Luo, Chuhong Zhu, Tian-Ran Li, Xindong Liu, Dingyu Zhang, Shuyang Zhang, Yi-Fang Ping, Ling Leng, Xiu-Wu Bian
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-11 (2023)
Abstract Severe neurological symptoms are associated with Coronavirus disease 2019 (COVID-19). However, the morphologic features, pathological nature and their potential mechanisms in patient brains have not been revealed despite evidence of neurotro
Externí odkaz:
https://doaj.org/article/69b7bb7621654d2382b8ee1570a265d5
Autor:
Qu-Jing Gai, Zhen Fu, Jiang He, Min Mao, Xiao-Xue Yao, Yan Qin, Xi Lan, Lin Zhang, Jing-Ya Miao, Yan-Xia Wang, Jiang Zhu, Fei-Cheng Yang, Hui-Min Lu, Ze-Xuan Yan, Fang-Lin Chen, Yu Shi, Yi-Fang Ping, You-Hong Cui, Xia Zhang, Xindong Liu, Xiao-Hong Yao, Sheng-Qing Lv, Xiu-Wu Bian, Yan Wang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-12 (2022)
Abstract Platelet-derived growth subunit A (PDGFA) plays critical roles in development of glioblastoma (GBM) with substantial evidence from TCGA database analyses and in vivo mouse models. So far, only platelet-derived growth receptor α (PDGFRA) has
Externí odkaz:
https://doaj.org/article/405264fc1e9d490c8dafcef11c97de0f
Autor:
Zhuang Li, Wen-Juan Fu, Xiao-Qing Chen, Shuai Wang, Ru-Song Deng, Xiao-Peng Tang, Kai-Di Yang, Qin Niu, Hong Zhou, Qing-Rui Li, Yong Lin, Mei Liang, Si-Si Li, Yi-Fang Ping, Xin-Dong Liu, Xiu-Wu Bian, Xiao-Hong Yao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-20 (2022)
Abstract Background Glioblastoma (GB) is the most common and highly malignant brain tumor characterized by aggressive growth and resistance to alkylating chemotherapy. Autophagy induction is one of the hallmark effects of anti-GB therapies with temoz
Externí odkaz:
https://doaj.org/article/202a414ee63146bebbe58aa60f445ecf
Autor:
Kaidi Yang, Yu Shi, Min Luo, Min Mao, Xiaoning Zhang, Cong Chen, Yuqi Liu, Zhicheng He, Qing Liu, Wenying Wang, Chunhua Luo, Wen Yin, Chao Wang, Qin Niu, Hui Zeng, Xiu-Wu Bian, Yi-Fang Ping
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Glioblastoma (GBM) is an aggressive primary brain tumor with unique immunity predominated by myeloid cells. GBM cells have been implicated to evade immune attack through hijacking myeloid-affiliated transcriptional programs to establish an immunosupp
Externí odkaz:
https://doaj.org/article/5b256bebf2654924af4cfe5568baf7b2
Autor:
Ling Leng, Jie Ma, Pei-Pei Zhang, Si-Chi Xu, Xiao Li, Ye Jin, Jun Cai, Rui Tang, Lei Zhao, Zhi-Cheng He, Man-Sheng Li, Hui Zhang, Liang-Rui Zhou, Zhi-Hong Wu, Tian-Ran Li, Yun-Ping Zhu, Yu-Jie Wang, Hai-Bo Wu, Yi-Fang Ping, Xiao-Hong Yao, Chu-Hong Zhu, Hai-Tao Guo, Le-Yong Tan, Zhi-Yong Liang, Xiu-Wu Bian, Shu-Yang Zhang
Publikováno v:
Cell Reports, Vol 39, Iss 11, Pp 110955- (2022)
Summary: Direct myocardial and vascular injuries due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-driven inflammation is the leading cause of acute cardiac injury associated with coronavirus disease 2019 (COVID-19). Howev
Externí odkaz:
https://doaj.org/article/6aca9676b8de42f7936385b39ceeca91
Autor:
Yu Shi, Yi-Fang Ping, Wenchao Zhou, Zhi-Cheng He, Cong Chen, Bai-Shi-Jiao Bian, Lin Zhang, Lu Chen, Xun Lan, Xian-Chao Zhang, Kai Zhou, Qing Liu, Hua Long, Ti-Wei Fu, Xiao-Ning Zhang, Mian-Fu Cao, Zhi Huang, Xiaoguang Fang, Xiuxing Wang, Hua Feng, Xiao-Hong Yao, Shi-Cang Yu, You-Hong Cui, Xia Zhang, Jeremy N Rich, Shideng Bao, Xiu-Wu Bian
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-17 (2017)
Tumour-associated macrophages (TAMs) facilitate malignant growth of glioblastoma (GBM). Here, the authors show that TAMs support glioma stem cell renewal via paracrine signalling to the pleiotrophin receptor PTPRZ1 and that blocking this axis results
Externí odkaz:
https://doaj.org/article/fc10d4b4ab8a4e3cb428bc0e73382649
Autor:
Xiu-Wu Bian, Yi-Fang Ping, Xia Zhang, You-Hong Cui, Xiao-Hong Yao, Kai Zhou, Zhi-Cheng He, Hua Long, Ti-Wei Fu, Hua-Liang Xiao, Hua-Rong Zhang, Jun Rao, Qing Liu, Shi-Zhu Yu, Cong Chen, Yu Shi
Supplementary Figure S4. The prognostic significance of miR-663 and CXCR4 in astrocytic glioma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bb9bfb4ab82552871f71e156bccca8f
https://doi.org/10.1158/1078-0432.22456761
https://doi.org/10.1158/1078-0432.22456761
Autor:
Xiu-Wu Bian, Yi-Fang Ping, Xia Zhang, You-Hong Cui, Xiao-Hong Yao, Kai Zhou, Zhi-Cheng He, Hua Long, Ti-Wei Fu, Hua-Liang Xiao, Hua-Rong Zhang, Jun Rao, Qing Liu, Shi-Zhu Yu, Cong Chen, Yu Shi
Supplementary tables from S1-S6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4598c18092014c7e6c9bebaa4b8b2387
https://doi.org/10.1158/1078-0432.22456755.v1
https://doi.org/10.1158/1078-0432.22456755.v1
Autor:
Xiu-Wu Bian, Yi-Fang Ping, Xia Zhang, You-Hong Cui, Xiao-Hong Yao, Kai Zhou, Zhi-Cheng He, Hua Long, Ti-Wei Fu, Hua-Liang Xiao, Hua-Rong Zhang, Jun Rao, Qing Liu, Shi-Zhu Yu, Cong Chen, Yu Shi
Purpose: To identify the miRNA regulators of C–X–C motif chemokine receptor 4 (CXCR4) and the underlying mechanism as well as the therapeutic and prognostic values in human glioblastoma (GBM).Experimental Design: miRNA profile analyses and bioinf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55f6ef028983ce5560ef65648dba3aa6
https://doi.org/10.1158/1078-0432.c.6523410.v1
https://doi.org/10.1158/1078-0432.c.6523410.v1
Autor:
Xiu-Wu Bian, Yi-Fang Ping, Shi-Zhu Yu, You-Hong Cui, Ling Liu, Chuan Xu, Wei Cui, Yong Ren, Zhi-Cheng He, Tao Jiang, Xiao-Hong Yao, Hua-Rong Zhang, Jin-Ling Xu, Qing Liu, Xia Zhang, Cong Chen, Yu Shi
PDF file - 455K, Supplementary Fig. S1. The prognostic values of miR-663 in GBM patients stratified by IDH1/ATRX status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395b87cb4b1669cd078105ba37b99464
https://doi.org/10.1158/1078-0432.22452569
https://doi.org/10.1158/1078-0432.22452569